XXXX thrombotherapy of esophageal varices: further experience.

@entity1 @entity548 @entity843 @entity1003 @entity1575 @entity715 @entity1068
Fifty @entity1 with @entity1575 (13 @entity1 class B, 37 class C) were treated for @entity548 during a 3-year period using the transhepatic selective catheterization and injection of absolute @entity1068 . Technical failure of the procedure was encountered in 13 instances. The causes were the presence of massive @entity843 and rigidly contracted liver, cavernous transformation of the main portal vein, and severe @entity1003 . Of the 13 failures, 12 were in @entity1 class C and one in class B. Of 37 initially successfully treated @entity1 , 13 rebled subsequently. Nine of these were @entity1 class C and four were class B. Rebleeding was fatal in five of nine class C @entity1 . Rebleeding was due to recanalization of previously thrombosed access channel in two of 13 @entity1 . Nine @entity1 died, despite successful @entity715 of varices, due to underlying medical conditions. Fifteen @entity1 survived 6 months or more after initial @entity715 without rebleeding. @entity1 class B @entity1 are better candidates for this treatment technique because more favorable treatment results are expected in them. @entity1 class C @entity1 with massive @entity843 and severely contracted and rigid liver pose a significant technical challenge, but in about one-third, successful control of variceal bleeding can be achieved. Most of those who survived more than 6 months showed varying degrees of improvement in clinical signs and symptoms.
